bioAffinity Technologies Inc (BIAFW) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.45M	1.59M	1.35M	1.51M
Cost of goods sold	942.21K	900.13K	928.64K	1.09M
Cost of revenue	942.21K	900.13K	928.64K	1.09M
Research and development expenses	473.90K	668.81K	683.75K	837.46K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.21M	3.04M	3.24M	2.86M
Operating expense	2.80M	3.83M	4.04M	3.76M
Total operating expenses	3.74M	4.73M	4.97M	4.85M
Operating income	-2.29M	-3.14M	-3.62M	-3.33M
Other non operating income	-2.75M	-3.98K	-8.94K	-22.89K
EBT including unusual items	-5.05M	-3.13M	-3.63M	-3.37M
EBT excluding unusual items	-5.05M	-3.13M	-3.63M	-3.37M
Income tax expense	3.18K	3.18K	-	-
Effective tax rate	-0.06%	-0.10%	-	-
Other operating expenses	-	-	-	-
Net income	-5.05M	-3.14M	-3.63M	-3.37M
Net profit margin	-349.30%	-196.98%	-268.63%	-222.83%
Earnings per share	-4.74	-	-	-
Interest and investment income	1.09K	19.73K	10.03K	3.36K
Interest expense	-5.36K	-13.07K	-14.72K	-11.69K
Net interest expenses	-4.27K	6.66K	-4.70K	-8.33K
Depreciation and amortization charges	113.36K	123.66K	114.52K	61.56K
EBITDA	-2.18M	-3.01M	-3.50M	-3.22M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance